标题
Cessation and reduction in alcohol consumption and misuse after psychedelic use
作者
关键词
-
出版物
JOURNAL OF PSYCHOPHARMACOLOGY
Volume -, Issue -, Pages 026988111984579
出版商
SAGE Publications
发表日期
2019-05-14
DOI
10.1177/0269881119845793
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety
- (2019) Alan K. Davis et al. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
- Predictors of positive drinking outcomes among youth receiving an alcohol brief intervention in the emergency department
- (2018) Alan K. Davis et al. DRUG AND ALCOHOL DEPENDENCE
- Psychedelics and the essential importance of context
- (2018) Robin L Carhart-Harris et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The epidemiology of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption
- (2018) Alan K Davis et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act
- (2018) Matthew W. Johnson et al. NEUROPHARMACOLOGY
- Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
- (2018) Fernanda Palhano-Fontes et al. PSYCHOLOGICAL MEDICINE
- Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States
- (2018) Deborah S. Hasin et al. JAMA Psychiatry
- The Psychedelic Debriefing in Alcohol Dependence Treatment: Illustrating Key Change Phenomena through Qualitative Content Analysis of Clinical Sessions
- (2018) Elizabeth M. Nielson et al. Frontiers in Pharmacology
- Ayahuasca and Its DMT- and β-carbolines – Containing Ingredients Block the Expression of Ethanol-Induced Conditioned Place Preference in Mice: Role of the Treatment Environment
- (2018) Elisangela G. Cata-Preta et al. Frontiers in Pharmacology
- Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
- (2018) Leor Roseman et al. Frontiers in Pharmacology
- Assessment of Alcohol and Tobacco Use Disorders Among Religious Users of Ayahuasca
- (2018) Paulo Cesar Ribeiro Barbosa et al. Frontiers in Psychiatry
- Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution
- (2018) M. V. Uthaug et al. PSYCHOPHARMACOLOGY
- A single administration of the hallucinogen, 4-acetoxy-dimethyltryptamine, prevents the shift to a drug-dependent state and the expression of withdrawal aversions in rodents
- (2017) Hector Vargas-Perez et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- An online survey of tobacco smoking cessation associated with naturalistic psychedelic use
- (2017) Matthew W Johnson et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Psychiatry & the psychedelic drugs. Past, present & future
- (2017) James J.H. Rucker et al. NEUROPHARMACOLOGY
- Why MDMA therapy for alcohol use disorder? And why now?
- (2017) Ben Sessa NEUROPHARMACOLOGY
- Regulation of human research with LSD in the United States (1949-1987)
- (2017) Katherine R. Bonson PSYCHOPHARMACOLOGY
- Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression
- (2017) J. B. Stroud et al. PSYCHOPHARMACOLOGY
- Long-lasting subjective effects of LSD in normal subjects
- (2017) Yasmin Schmid et al. PSYCHOPHARMACOLOGY
- Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects
- (2017) F Mueller et al. Translational Psychiatry
- The Effectiveness of Psychosocial Modalities in the Treatment of Alcohol Problems in Adults: A Review of the Evidence
- (2017) Garth W Martin et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms
- (2017) Robin L Carhart-Harris et al. Scientific Reports
- Alcohol consumption as a cause of cancer
- (2016) Jennie Connor ADDICTION
- Psychedelics as Medicines: An Emerging New Paradigm
- (2016) DE Nichols et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical applications of hallucinogens: A review.
- (2016) Albert Garcia-Romeu et al. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
- (2016) Roland R Griffiths et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
- (2016) Stephen Ross et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology
- (2016) Ido Hartogsohn JOURNAL OF PSYCHOPHARMACOLOGY
- LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality
- (2016) Patrick C Dolder et al. NEUROPSYCHOPHARMACOLOGY
- Effects of serotonin 2A/1A receptor stimulation on social exclusion processing
- (2016) Katrin H. Preller et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The role of pro-inflammatory cytokines in neuroinflammation, neurogenesis and the neuroendocrine system in major depression
- (2016) Yong-Ku Kim et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Alterations of consciousness and mystical-type experiences after acute LSD in humans
- (2016) Matthias E. Liechti et al. PSYCHOPHARMACOLOGY
- Antidepressive and anxiolytic effects of ayahuasca: a systematic literature review of animal and human studies
- (2016) Rafael G. dos Santos et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Long-term follow-up of psilocybin-facilitated smoking cessation
- (2016) Matthew W. Johnson et al. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
- The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity
- (2016) Rainer Kraehenmann et al. NeuroImage-Clinical
- Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers
- (2015) Rainer Kraehenmann et al. BIOLOGICAL PSYCHIATRY
- Can psychedelic compounds play a part in drug dependence therapy?
- (2015) Ben Sessa et al. BRITISH JOURNAL OF PSYCHIATRY
- Psychedelic medicine: a re-emerging therapeutic paradigm
- (2015) Kenneth W. Tupper et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: A systematic review and meta-analysis
- (2015) Harry Man Xiong Lai et al. DRUG AND ALCOHOL DEPENDENCE
- Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population
- (2015) Peter S Hendricks et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin
- (2015) Frederick S Barrett et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Peak experiences and the afterglow phenomenon: When and how do therapeutic effects of hallucinogens depend on psychedelic experiences?
- (2015) Tomislav Majić et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
- (2015) Michael P Bogenschutz et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Effects of ayahuasca on the development of ethanol-induced behavioral sensitization and on a post-sensitization treatment in mice
- (2015) A.J. Oliveira-Lima et al. PHYSIOLOGY & BEHAVIOR
- Epidemiology ofDSM-5Alcohol Use Disorder
- (2015) Bridget F. Grant et al. JAMA Psychiatry
- Do Patients With Alcohol Dependence Respond to Placebo? Results From the COMBINE Study
- (2015) Roger D. Weiss et al. Journal of Studies on Alcohol and Drugs
- The Psychedelic State Induced by Ayahuasca Modulates the Activity and Connectivity of the Default Mode Network
- (2015) Fernanda Palhano-Fontes et al. PLoS One
- Enhanced repertoire of brain dynamical states during the psychedelic experience
- (2014) Enzo Tagliazucchi et al. HUMAN BRAIN MAPPING
- Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
- (2014) Peter Gasser et al. JOURNAL OF NERVOUS AND MENTAL DISEASE
- Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction
- (2014) Matthew W Johnson et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Contribution of Excessive Alcohol Consumption to Deaths and Years of Potential Life Lost in the United States
- (2014) Mandy Stahre et al. Preventing Chronic Disease
- Behavioral Counseling After Screening for Alcohol Misuse in Primary Care: A Systematic Review and Meta-analysis for the U.S. Preventive Services Task Force
- (2013) Daniel E. Jonas et al. ANNALS OF INTERNAL MEDICINE
- Dimethyltryptamine (DMT): Prevalence, user characteristics and abuse liability in a large global sample
- (2013) Adam R Winstock et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Effects of Schedule I drug laws on neuroscience research and treatment innovation
- (2013) David J. Nutt et al. NATURE REVIEWS NEUROSCIENCE
- Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?
- (2012) Natalya C. Maisel et al. ADDICTION
- Psilocybin Biases Facial Recognition, Goal-Directed Behavior, and Mood State Toward Positive Relative to Negative Emotions Through Different Serotonergic Subreceptors
- (2012) Michael Kometer et al. BIOLOGICAL PSYCHIATRY
- Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses
- (2012) Michael P. Bogenschutz et al. Drug Testing and Analysis
- Health status of ayahuasca users
- (2012) Paulo Cesar Ribeiro Barbosa et al. Drug Testing and Analysis
- Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials
- (2012) Teri S Krebs et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
- (2012) R. L. Carhart-Harris et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Efficacy of Disulfiram for the Treatment of Alcohol Use Disorder
- (2011) Charlotte H. Jørgensen et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Induction of innate immune genes in brain create the neurobiology of addiction
- (2011) F.T. Crews et al. BRAIN BEHAVIOR AND IMMUNITY
- Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness
- (2011) Katherine A MacLean et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
- (2011) Roland R. Griffiths et al. PSYCHOPHARMACOLOGY
- Spirituality in Recovery: A Lagged Mediational Analysis of Alcoholics Anonymous’ Principal Theoretical Mechanism of Behavior Change
- (2010) John F. Kelly et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
- (2010) Charles S. Grob et al. ARCHIVES OF GENERAL PSYCHIATRY
- Assessment of addiction severity among ritual users of ayahuasca
- (2010) Josep Maria Fábregas et al. DRUG AND ALCOHOL DEPENDENCE
- Spirituality during Alcoholism Treatment and Continuous Abstinence for One Year
- (2009) Katherine M. Piderman et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE
- Human hallucinogen research: guidelines for safety
- (2008) MW Johnson et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
- (2008) RR Griffiths et al. JOURNAL OF PSYCHOPHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search